Woodward (NASDAQ:WWD – Get Free Report) had its target price raised by stock analysts at UBS Group from $209.00 to $228.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the technology company’s stock. UBS Group’s price objective suggests a potential upside of 27.34% from the company’s previous close.
Several other equities research analysts also recently issued reports on WWD. Truist Financial reaffirmed a “buy” rating and set a $226.00 price target (up previously from $187.00) on shares of Woodward in a research note on Tuesday. TD Cowen reaffirmed a “hold” rating and set a $160.00 target price (down from $186.00) on shares of Woodward in a research report on Friday, October 4th. Deutsche Bank Aktiengesellschaft boosted their price target on Woodward from $158.00 to $162.00 and gave the stock a “hold” rating in a research note on Thursday, October 3rd. The Goldman Sachs Group lowered their price objective on Woodward from $228.00 to $201.00 and set a “buy” rating for the company in a research note on Wednesday, July 31st. Finally, StockNews.com cut Woodward from a “buy” rating to a “hold” rating in a research note on Friday, November 22nd. Six analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average target price of $184.67.
Check Out Our Latest Stock Analysis on Woodward
Woodward Stock Down 4.4 %
Insider Activity
In related news, COO Thomas G. Cromwell sold 7,913 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $175.13, for a total value of $1,385,803.69. Following the completion of the transaction, the chief operating officer now directly owns 11,511 shares of the company’s stock, valued at $2,015,921.43. This represents a 40.74 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In the last three months, insiders sold 27,913 shares of company stock valued at $4,907,304. Company insiders own 1.12% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of the business. Tidal Investments LLC increased its stake in shares of Woodward by 66.9% during the first quarter. Tidal Investments LLC now owns 2,548 shares of the technology company’s stock valued at $393,000 after acquiring an additional 1,021 shares during the period. Cetera Advisors LLC acquired a new position in Woodward during the first quarter worth about $229,000. GAMMA Investing LLC raised its position in Woodward by 82.8% in the second quarter. GAMMA Investing LLC now owns 660 shares of the technology company’s stock worth $115,000 after acquiring an additional 299 shares in the last quarter. Versant Capital Management Inc acquired a new stake in Woodward in the 2nd quarter valued at about $69,000. Finally, Park Avenue Securities LLC boosted its position in shares of Woodward by 2.4% during the 2nd quarter. Park Avenue Securities LLC now owns 3,277 shares of the technology company’s stock valued at $571,000 after purchasing an additional 76 shares in the last quarter. 81.18% of the stock is owned by institutional investors and hedge funds.
Woodward Company Profile
Woodward, Inc designs, manufactures, and services control solutions for the aerospace and industrial markets worldwide. The company operates in two segments, Aerospace and Industrial. The Aerospace segment provides fuel pumps, metering units, actuators, air valves, specialty valves, fuel nozzles, and thrust reverser actuation systems for turbine engines and nacelles, and flight deck controls, actuators, servocontrols, motors, and sensors for aircraft.
Featured Articles
- Five stocks we like better than Woodward
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Following Congress Stock Trades
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Canada Bond Market Holiday: How to Invest and Trade
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Woodward Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Woodward and related companies with MarketBeat.com's FREE daily email newsletter.